| MeSH term | MeSH ID | Detail |
|---|---|---|
| Edema | D004487 | 152 associated lipids |
| Angina Pectoris | D000787 | 27 associated lipids |
| Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
Total
3
Tribehenin
Tribehenin is a lipid of Glycerolipids (GL) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Tribehenin
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Tribehenin
NCBI Entrez Crosslinks
All references with Tribehenin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Negi JS et al. | Development and evaluation of glyceryl behenate based solid lipid nanoparticles (SLNs) using hot self-nanoemulsification (SNE) technique. | 2014 | Arch. Pharm. Res. | pmid:23695866 |
| Shah MK et al. | Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration. | 2014 | Pharm Dev Technol | pmid:23697916 |
| Vithani K et al. | Diclofenac sodium sustained release hot melt extruded lipid matrices. | 2014 | Pharm Dev Technol | pmid:23763447 |
| Pradhan R et al. | Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate. | 2014 | Int J Pharm | pmid:24184032 |
| Siram K et al. | Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation. | 2014 | Expert Opin Drug Deliv | pmid:24847779 |
| Uğurlu T and Halaçoğlu MD | Effects of some lubricants and evaluation of compression parameters on directly compressible powders. | 2014 | Pharm Dev Technol | pmid:23590449 |
| Tran TH et al. | Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement. | 2014 | AAPS PharmSciTech | pmid:25035071 |
| Scalia S et al. | Comparison of spray congealing and melt emulsification methods for the incorporation of the water-soluble salbutamol sulphate in lipid microparticles. | 2013 | Pharm Dev Technol | pmid:22998063 |
| Stanisz B et al. | Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations. | 2013 | Drug Dev Ind Pharm | pmid:22348774 |
| Bose S and Michniak-Kohn B | Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. | 2013 | Eur J Pharm Sci | pmid:23246734 |